Advances in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasms, and Pancreatitis
- PMID: 29753841
- PMCID: PMC6785012
- DOI: 10.1053/j.gastro.2018.05.019
Advances in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasms, and Pancreatitis
Abstract
According to the theme of the Golden Jubilee Issue of our journal, we present a commentary on landmark contributions reported in the journal on pancreatic cancer, pancreatic cysts, and intraductal papillary mucinous neoplasms (IPMN) and pancreatitis.
Conflict of interest statement
Conflicts of interest
The author discloses no conflicts.
References
-
- Wang Z, Lai ST, Xie L, et al. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res Clin Pract 2014;106:19–26. - PubMed
-
- Schneider MB, Matsuzaki H, Haorah J, et al. Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology 2001;120:1263–1270. - PubMed
-
- Bachem MG, Schunemann M, Ramadani M, et al. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 2005;128:907–921. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
